In the presence of gut dysbiosis, such as in HCC, BCAA levels increased not only in plasma but even in the tumor tissue and the surrounding area; interestingly, the downregulation of the catabolic enzymes of BCAAs is reported in tumor cells, leading to BCAA accumulation and mTORC1 activation. This evidence concerns the gene ARID4B and hepatocellular carcinoma.